Cancer BiologybioRxivPreprint
Elimusertib outperforms standard of care chemotherapy in preclinical patient-derived pediatric solid tumor models
F. F. Pusch, H. Dorado Garcia, R. Xu…·A. G. Henssen
This paper evaluates elimusertib's preclinical efficacy in pediatric solid tumor models, finding it outperforms standard chemotherapy, especially in alveolar rhabdomysarcoma.
DOI 10.1101/2022.11.10.515290